CytoDyn Inc. (CYDY) stock
CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
$0.25+0.02 (+9.53%)
Close on Oct 19, 2026Market cap $345.56MP/E –Yield –
CytoDyn operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
CytoDyn's operating cash flow for the twelve months ending Aug 31, 2026 was -$22.53M. For fiscal 2026 it was -$17.25M. The highest annual figure on record is -$1.82M in fiscal 2011.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | -$17.25M | – |
| FY2025 | May 31, 2025 | -$8.77M | – |
| FY2024 | May 31, 2024 | -$10.98M | – |
| FY2023 | May 31, 2023 | -$25.11M | – |
| FY2022 | May 31, 2022 | -$77.72M | – |
| FY2021 | May 31, 2021 | -$117.57M | – |
| FY2020 | May 31, 2020 | -$68.80M | – |
| FY2019 | May 31, 2019 | -$50.47M | – |
| FY2018 | May 31, 2018 | -$29.90M | – |
| FY2017 | May 31, 2017 | -$26.73M | – |
| FY2016 | May 31, 2016 | -$24.81M | – |
| FY2015 | May 31, 2015 | -$12.02M | – |
| FY2014 | May 31, 2014 | -$7.39M | – |
| FY2013 | May 31, 2013 | -$3.39M | – |
| FY2012 | May 31, 2012 | -$4.39M | – |
| FY2011 | May 31, 2011 | -$1.82M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -$7.73M | – |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -$4.93M | – |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$5.52M | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$4.35M | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$2.45M | -145.0% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -$5.66M | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$4.96M | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$3.59M | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $5.44M | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -$1.65M | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$2.34M | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -$2.50M | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$4.50M | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$4.41M | – |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -$11.07M | – |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -$6.04M | – |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | -$11.05M | – |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -$28.89M | – |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -$31.74M | – |
| Q4 FY2021CQ2 2021 | May 31, 2021 | -$32.81M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | -$23.65M | – |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | -$20.17M | – |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | -$40.95M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$29.31M | – |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | -$17.52M | – |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | -$6.79M | – |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | -$15.19M | – |
| Q4 FY2019CQ2 2019 | May 31, 2019 | -$9.51M | – |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | -$14.76M | – |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | -$17.22M | – |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | -$8.97M | – |
| Q4 FY2018CQ2 2018 | May 31, 2018 | -$6.98M | – |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | -$10.03M | – |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | -$5.89M | – |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | -$7.00M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | -$7.17M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | -$8.79M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | -$4.51M | – |
| Q1 FY2017CQ3 2016 | Aug 31, 2016 | -$6.26M | – |
See a number that looks wrong?